参考文献 References
[1] Seguin, L., Durandy, M., and Feral, C.C. (2022). Lung Adenocarcinoma Tumor Origin: A Guide for Personalized Medicine. Cancers (Basel) 14. 10.3390/cancers14071759.
[2] 王佳庆, 宁霄, 余克富, 汪祺, and 史卫忠 (2024). 基于生物信息学的CD39对肺腺癌免疫微环境及其免疫治疗的影响分析. 药物评价研究 47, 490-495.
[3] Lim, J.U., Lee, E., Lee, S.Y., Cho, H.J., Ahn, D.H., Hwang, Y., Choi, J.Y., Yeo, C.D., Park, C.K., and Kim, S.J. (2023). Current literature review on the tumor immune micro-environment, its heterogeneity and future perspectives in treatment of advanced non-small cell lung cancer. Transl Lung Cancer Res 12, 857-876. 10.21037/tlcr-22-633.
[4] Seo, J.S., Kim, A., Shin, J.Y., and Kim, Y.T. (2018). Comprehensive analysis of the tumor immune micro-environment in non-small cell lung cancer for efficacy of checkpoint inhibitor. Sci Rep 8, 14576. 10.1038/s41598-018-32855-8.
[5] Bejarano, L., Jordao, M.J.C., and Joyce, J.A. (2021). Therapeutic Targeting of the Tumor Microenvironment. Cancer Discov 11, 933-959. 10.1158/2159-8290.CD-20-1808.
[6] de Visser, K.E., and Joyce, J.A. (2023). The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell 41, 374-403. 10.1016/j.ccell. 2023.02.016.
[7] Mun, J.Y., Leem, S.H., Lee, J.H., and Kim, H.S. (2022). Dual Relationship Between Stromal Cells and Immune Cells in the Tumor Microenvironment. Front Immunol 13, 864739. 10.3389/fimmu.2022.864739.
[8] Seager, R.J., Hajal, C., Spill, F., Kamm, R.D., and Zaman, M.H. (2017). Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression. Converg Sci Phys Oncol 3. 10.1088/2057-1739/aa7e86.
[9] Hanahan, D., Michielin, O., and Pittet, M.J. (2025). Convergent inducers and effectors of T cell paralysis in the tumour microenvironment. Nat Rev Cancer 25, 41-58. 10.1038/s41568-024-00761-z.
[10] 林贯川, and 潘星华 (2025). 单细胞与空间组学的技术前沿、计算范式及新兴挑战. 中国生物化学与分子生物学报 41, 1559-1565. 10.13865/j.cnki.cjbmb.2025.10.0001.
[11] Puram, S.V., Tirosh, I., Parikh, A.S., Patel, A.P., Yizhak, K., Gillespie, S., Rodman, C., Luo, C.L., Mroz, E.A., Emerick, K.S., et al. (2017). Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer. Cell 171, 1611-1624 e1624. 10.1016/j.cell. 2017.10.044.
[12] Lavin, Y., Kobayashi, S., Leader, A., Amir, E.D., Elefant, N., Bigenwald, C., Remark, R., Sweeney, R., Becker, C.D., Levine, J.H., et al. (2017). Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses. Cell 169, 750-765 e717. 10.1016/j.cell.2017. 04.014.
[13] Kim, N., Kim, H.K., Lee, K., Hong, Y., Cho, J.H., Choi, J.W., Lee, J.I., Suh, Y.L., Ku, B.M., Eum, H.H., et al. (2020). Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nat Commun 11, 2285. 10.1038/s41467-020-16164-1.
[14] Cui, H., Wang, C., Maan, H., Pang, K., Luo, F., Duan, N., and Wang, B. (2024). scGPT: toward building a foundation model for single-cell multi-omics using generative AI. Nat Methods 21, 1470-1480. 10.1038/s41592-024-02201-0.
[15] Qiu, X., Mao, Q., Tang, Y., Wang, L., Chawla, R., Pliner, H.A., and Trapnell, C. (2017). Reversed graph embedding resolves complex single-cell trajectories. Nat Methods 14, 979-982. 10.1038/nmeth.4402.
[16] Jin, S., Guerrero-Juarez, C.F., Zhang, L., Chang, I., Ramos, R., Kuan, C.H., Myung, P., Plikus, M.V., and Nie, Q. (2021). Inference and analysis of cell-cell communication using CellChat. Nat Commun 12, 1088. 10.1038/s41467-021-21246-9.
[17] Fagerberg, E., Attanasio, J., Dien, C., Singh, J., Kessler, E.A., Abdullah, L., Shen, J., Hunt, B.G., Connolly, K.A., De Brouwer, E., et al. (2025). KLF2 maintains lineage fidelity and suppresses CD8 T cell exhaustion during acute LCMV infection. Science 387, eadn2337. 10.1126/science. adn2337.
[18] Bai, Y., Hu, M., Chen, Z., Wei, J., and Du, H. (2021). Single-Cell Transcriptome Analysis Reveals RGS1 as a New Marker and Promoting Factor for T-Cell Exhaustion in Multiple Cancers. Front Immunol 12, 767070. 10.3389/fimmu.2021.767070.
[19] Worboys, J.D., Vowell, K.N., Hare, R.K., Ambrose, A.R., Bertuzzi, M., Conner, M.A., Patel, F.P., Zammit, W.H., Gali-Moya, J., Hazime, K.S., et al. (2023). TIGIT can inhibit T cell activation via ligation-induced nanoclusters, independent of CD226 co-stimulation. Nat Commun 14, 5016. 10.1038/s41467-023-40755-3.
[20] Jo, Y., Jin, H.S., and Park, Y. (2024). No more LAGging behind PD-1: uncovering the unique role of LAG-3 in T-cell exhaustion. Cell Mol Immunol 21, 1351-1353. 10.1038/s41423-024-01227-w.
[21] Hou, L., Jiang, M., Li, Y., Cheng, J., Liu, F., Han, X., Guo, J., Feng, L., Li, Z., Yi, J., et al. (2025). Targeting SPP1(+) macrophages via the SPP1-CD44 axis reveals a key mechanism of immune suppression and tumor progression in ovarian cancer. Int Immunopharmacol 160, 114906. 10.1016/j.intimp.2025.114906.